http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2283738-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51803ff72e5c8f9bef5cb4de32f2d6e2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375 |
| filingDate | 1998-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b60e6eea42c1e799a9b68efbd2f524a9 |
| publicationDate | 1998-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2283738-A1 |
| titleOfInvention | Ascorbic acid as an adjuvant in the removal of vascular occlusions |
| abstract | The invention relates to the use of ascorbic acid or one of its physiologically tolerable salts for producing a medicament which contains 5 to 50g of ascorbic acid and is used as an adjuvant in the removal of occular occlusions. The invention also relates to combined preparations which contain large-dose ascorbic acid together with .alpha.-tocopherol compounds and/or thrombolytically active compounds. |
| priorityDate | 1997-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.